Actively Recruiting
A Fruit and Vegetable Prescription Program
Led by Milton S. Hershey Medical Center · Updated on 2025-11-21
120
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
Sponsors
M
Milton S. Hershey Medical Center
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of servings each day. F\&V prescription (F\&V Rx) programs are embedded into clinical settings and provide patients with vouchers to purchase F\&V at local retailers. The proposed study aims to test the effects of a F\&V Rx on diabetes self-management education and support (DSME/S) uptake and retention, dietary intake of F\&V and diet quality, glucose control (hemoglobin A1c), and program implementation outcomes.
CONDITIONS
Official Title
A Fruit and Vegetable Prescription Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient at Penn State Health St. Joe's Medical Center
- Diagnosis of Type 2 Diabetes Mellitus for at least six months
- Hemoglobin A1c level is 7% or higher (53 mmol/mol)
- Low income defined by enrollment in Supplemental Nutrition Assistance Program (SNAP), being uninsured or having Medicaid, or food insecurity based on USDA criteria
- Ability to provide a blood sample
- Willing to respond to contacts from study staff during the study period
- Willing and able to give informed consent
- Can read and write in English or Spanish
You will not qualify if you...
- Diagnosis of Type 2 Diabetes Mellitus less than six months
- Previous participation in the Veggie Rx program within the past year
- Attendance at any diabetes self-management education and support (DSME/S) sessions in the past year
- Women who are pregnant or plan to become pregnant during the study period
- Any uncontrolled mental illness or substance abuse or inpatient treatment for these in the past six months
- Any unstable or significant medical condition in the past three months (e.g., recent heart attack, stroke, deep vein thrombosis)
- Hemoglobin A1c level less than 7%
- Does not speak English or Spanish
- Unable to provide informed consent
- Unable to give a blood sample
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Penn State Health St. Joseph Downtown Campus
Reading, Pennsylvania, United States, 19601
Actively Recruiting
Research Team
S
Susan Veldheer, DEd, RD
CONTACT
K
Kayla N Rutt, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here